FDA Approved: MODAFINIL — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for a generic modafinil product (ANDA077667), enabling its marketing in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea-hypopnea Syndrome
• Shift Work Sleep Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

SUPPL AP for MODAFINIL (MODAFINIL)